Sentinel lymph node biopsy and axillary staging of T1-T2 N0 breast cancer: a multicenter study

Semin Surg Oncol. 1998 Dec;15(4):278-83. doi: 10.1002/(sici)1098-2388(199812)15:4<278::aid-ssu18>3.0.co;2-9.

Abstract

From December 1996 to May 1998, 84 T1-T2 NO breast cancer patients were recruited for a multicenter study on the lymphoscintigraphic search of the axillary sentinel lymph node (SLN). The SLN was searched intraoperatively with a sodium iodide hand-held gamma-detecting probe (GDP) and excised before the standard axillary dissection was performed. Lymphoscintigraphy was unsuccessful in 8 of 84 cases (9.5%). In 73 of 76 patients with positive lymphoscintigraphy, SLN were found and excised (96%). The SLN proved to be predictive of axillary status in 71 of 73 cases (97.2%). Thirty of 41 patients had axillary metastases: in 16 cases, the SLN was the only site of the metastases (50%). In two cases, the SLN (reactive) did not match with the axillary status (2 of 63 reactive SLN, 4.6% of "skip" metastases). Age, tumor diameter, and histology seem to have little importance in affecting the predictivity of SLN biopsy. These results demonstrate the applicability of the lymphatic mapping techniques to a multicenter setting.

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Axilla
  • Biopsy
  • Breast Neoplasms / diagnostic imaging*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery
  • Carcinoma, Ductal, Breast / diagnostic imaging
  • Carcinoma, Ductal, Breast / secondary
  • Carcinoma, Ductal, Breast / surgery
  • Carcinoma, Lobular / diagnostic imaging
  • Carcinoma, Lobular / secondary
  • Carcinoma, Lobular / surgery
  • False Negative Reactions
  • Female
  • Humans
  • Intraoperative Period
  • Lymph Nodes / diagnostic imaging
  • Lymph Nodes / pathology*
  • Lymphatic Metastasis
  • Neoplasm Staging
  • Predictive Value of Tests
  • Prognosis
  • Radioimmunodetection*
  • Technetium Tc 99m Aggregated Albumin

Substances

  • Technetium Tc 99m Aggregated Albumin